Skip Navigation

JNCI Journal of the National Cancer Institute 2000 92(12):957; doi:10.1093/jnci/92.12.957
© 2000 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 92, No. 12, 957, June 21, 2000
© 2000 Oxford University Press

IN THIS ISSUE

Clinical Breast Examinations and Breast Cancer

Bobo et al. (p. 971) analyzed data from 752,081 clinical breast examinations (CBEs) from the National Breast and Cervical Cancer Early Detection Program to determine the percentage of CBEs considered abnormal (suspicious for cancer), the rates of cancer detection, and the sensitivity and specificity of CBEs. They report that 6.9% (about one in 15) of all CBEs were coded as abnormal, and they found that five cancers were detected per 1000 CBEs. They determined that the sensitivity and specificity were comparable to those reported for the . . . [Full Text of this Article]

Vitamin A, N-Acetylcysteine, and Tumor Recurrence

c-erbB2 and Chemosensitivity

Diurnal Cortisol Rhythms and Metastatic Breast Cancer

{alpha}-Fetoprotein and Maternal Breast Cancer


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?